2 results
Approved WMORecruiting
Primary:To evaluate the efficacy and safety of anakinra in the treatment of pain in patients with an acute gout attack during 3 days and subsequently assess the effect of anakinra treatment for 21 days in the prevention of recurrent gout attacks.…
Approved WMORecruiting
To determine the influence of esomeprazole on the AUC of regorafenib in patients with mCRC or GIST.